Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

NCT01972217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Olaparib
DRUG: Placebo
DRUG: Abiraterone
DRUG: Prednisone or prednisolone

Sponsor

AstraZeneca

Collaborators

[object Object]